EVIDENCE COMPARISON

Directional

Clobetasol
vs Cysteamine
for Pigmentation Reduction

Early or indirect evidence suggests clobetasol and cysteamine show equal performance for reducing pigmentation and improving skin tone, based on indirect comparison.

1.00x

Effect ratio

Neither

Favored

2

Studies

Indirect

Comparison

ExploratoryEstimated endpointTone

Limits: Indirect comparison · Includes estimated measurement · Early-stage evidence tier

This is an indirect comparison — the two ingredients were not tested head-to-head in the same trial. The ratio is derived from separate studies against a common comparator.

How to read this claim

Kept public as exploratory because it indirect comparison; includes estimated measurement; early-stage evidence tier.

Some study-specific context may affect how broadly this comparison generalizes.

Source Studies (2)

Role of Antioxidants in Melasma: A Systematic Review

randomized, double-blind

Sequential therapy with topical clobetasol for 14 days followed by hydroquinone versus hydroquinone alone in facial melasma treatment: a randomized, double-blind, controlled clinical trial.

controlled
Explore all comparisons →